Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 5, 2002
[Hodgkin's disease presenting with progressive liver failure]Masaharu Nohgawa, Noboru Yonetani, Tateo Sugiyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 14, 2010
[Multiple autologous transplantations with intermediate-dose melphalan for two elderly patients with relapsed or refractory diffuse large B-cell lymphoma]Tetsuo Nishimoto, Kazuo Hatanaka, Akihito Matsuoka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2016
[Successful treatment of an overwhelming infection with granulocyte transfusion in severe aplastic anemia patient undergoing allogeneic peripheral blood stem cell transplantation]Yasuhiro Kazuma, Yuichiro Ono, Noboru Yonetani, et al.
Blood Cell Therapy|December 27, 2023
Early prediction of cytokine release syndrome by measuring phosphate and magnesium levels following chimeric antigen receptor T cell therapyMasahiro Yoshida, Yoshinori Matsuoka, Satoshi Mitsuyuki, et al.
Internal Medicine (Tokyo, Japan)|June 4, 2013
The need for continuing chemotherapy for leukemic cell lysis pneumopathy in patients with acute myelomonocytic/monocytic leukemiaAiko Kato, Yuichiro Ono, Yosuke Nagahata, et al.
International Journal of Hematology|January 30, 2015
Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapyYotaro Ochi, Nobuhiro Hiramoto, Hiroshi Takegawa, et al.
World Journal of Surgical Oncology|January 15, 2011
An operative case of hepatic pseudolymphoma difficult to differentiate from primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissueMichihiro Hayashi, Noboru Yonetani, Fumitoshi Hirokawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 7, 2018
[Mitoxantrone, etoposide, and cytarabine combination therapy for acute myeloid leukemia patients failing to achieve a complete remission after induction chemotherapy: a single-center experience]Mari Morita-Fujita, Tomohiro Yabushita, Yoshimitsu Shimomura, et al.
Pageof 2